FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR.

Trial Profile

FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jun 2015

At a glance

  • Drugs Exenatide (Primary) ; Insulin aspart; Insulin glargine; Insulin glulisine; Insulin lispro; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms FLAT-SUGAR
  • Most Recent Events

    • 09 Jun 2015 Primary endpoint 'Glucose level (coefficient of variation of continuous glucose readings)' has been met as reported by abstract presented at 75th Annual Scientific Sessions of the American Diabetes Association.
    • 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
    • 17 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top